Virtus ETF Advisers’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.4K | Sell |
13,817
-41,614
| -75% | -$143K | 0.06% | 228 |
|
|
2025
Q1 | $164K | Buy |
+55,431
| New | +$164K | 0.21% | 111 |
|
|
2019
Q4 | – | Sell |
-54,053
| Closed | -$582K | – | 494 |
|
|
2019
Q3 | $582K | Sell |
54,053
-9,089
| -14% | -$97.9K | 0.12% | 174 |
|
|
2019
Q2 | $803K | Buy |
63,142
+29,764
| +89% | +$379K | 0.17% | 184 |
|
|
2019
Q1 | $1.3M | Buy |
33,378
+7,119
| +27% | +$276K | 2.76% | 2 |
|
|
2018
Q4 | $534K | Buy |
26,259
+12,032
| +85% | +$245K | 0.09% | 74 |
|
|
2018
Q3 | $652K | Buy |
14,227
+975
| +7% | +$44.7K | 0.07% | 80 |
|
|
2018
Q2 | $784K | Buy |
13,252
+4,123
| +45% | +$244K | 0.69% | 40 |
|
|
2018
Q1 | $621K | Sell |
9,129
-532
| -6% | -$36.2K | 0.54% | 103 |
|
|
2017
Q4 | $955K | Buy |
9,661
+5,514
| +133% | +$545K | 1.2% | 31 |
|
|
2017
Q3 | $497K | Buy |
4,147
+380
| +10% | +$45.5K | 0.07% | 90 |
|
|
2017
Q2 | $329K | Sell |
3,767
-4,380
| -54% | -$383K | 0.05% | 99 |
|
|
2017
Q1 | $303K | Buy |
8,147
+781
| +11% | +$29K | 0.05% | 133 |
|
|
2016
Q4 | $226K | Sell |
7,366
-300
| -4% | -$9.2K | 0.07% | 165 |
|
|
2016
Q3 | $514K | Hold |
7,666
| – | – | 0.25% | 69 |
|
|
2016
Q2 | $228K | Buy |
7,666
+4,345
| +131% | +$129K | 0.17% | 117 |
|
|
2016
Q1 | $98K | Buy |
+3,321
| New | +$98K | 0.14% | 146 |
|